Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports

Our article Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review had instigated a critique that there were more cases of post-COVID-19-vaccination NMOSD. Indeed, after the systematic review was performed in July 2021, many reports have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Tisavipat, Nanthaya, Anamnart, Chumpol, Owattanapanich, Weerapat, Apiwattanakul, Metha, Savangned, Pakawee, Prayoonwiwat, Naraporn, Siritho, Sasitorn, Rattanathamsakul, Natthapon, Jitprapaikulsan, Jiraporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273309/
https://www.ncbi.nlm.nih.gov/pubmed/35843141
http://dx.doi.org/10.1016/j.msard.2022.104055
_version_ 1784745044093173760
author Tisavipat, Nanthaya
Anamnart, Chumpol
Owattanapanich, Weerapat
Apiwattanakul, Metha
Savangned, Pakawee
Prayoonwiwat, Naraporn
Siritho, Sasitorn
Rattanathamsakul, Natthapon
Jitprapaikulsan, Jiraporn
author_facet Tisavipat, Nanthaya
Anamnart, Chumpol
Owattanapanich, Weerapat
Apiwattanakul, Metha
Savangned, Pakawee
Prayoonwiwat, Naraporn
Siritho, Sasitorn
Rattanathamsakul, Natthapon
Jitprapaikulsan, Jiraporn
author_sort Tisavipat, Nanthaya
collection PubMed
description Our article Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review had instigated a critique that there were more cases of post-COVID-19-vaccination NMOSD. Indeed, after the systematic review was performed in July 2021, many reports have been published, and we have seen two new patients at our center as well. However, Finsterer's question on the subclinical activity of NMOSD prior to vaccination, although an interesting notion, was debatable. NMOSD is a relapsing disease with severe attacks. Investigations in our patients did not reveal robust evidence of prior subclinical attacks so far.
format Online
Article
Text
id pubmed-9273309
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92733092022-07-12 Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports Tisavipat, Nanthaya Anamnart, Chumpol Owattanapanich, Weerapat Apiwattanakul, Metha Savangned, Pakawee Prayoonwiwat, Naraporn Siritho, Sasitorn Rattanathamsakul, Natthapon Jitprapaikulsan, Jiraporn Mult Scler Relat Disord Correspondence Our article Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review had instigated a critique that there were more cases of post-COVID-19-vaccination NMOSD. Indeed, after the systematic review was performed in July 2021, many reports have been published, and we have seen two new patients at our center as well. However, Finsterer's question on the subclinical activity of NMOSD prior to vaccination, although an interesting notion, was debatable. NMOSD is a relapsing disease with severe attacks. Investigations in our patients did not reveal robust evidence of prior subclinical attacks so far. Elsevier B.V. 2022-10 2022-07-12 /pmc/articles/PMC9273309/ /pubmed/35843141 http://dx.doi.org/10.1016/j.msard.2022.104055 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Tisavipat, Nanthaya
Anamnart, Chumpol
Owattanapanich, Weerapat
Apiwattanakul, Metha
Savangned, Pakawee
Prayoonwiwat, Naraporn
Siritho, Sasitorn
Rattanathamsakul, Natthapon
Jitprapaikulsan, Jiraporn
Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title_full Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title_fullStr Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title_full_unstemmed Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title_short Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
title_sort author's response to the commentary: neuromyelitis optica complicating covid vaccinations and additional case reports
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273309/
https://www.ncbi.nlm.nih.gov/pubmed/35843141
http://dx.doi.org/10.1016/j.msard.2022.104055
work_keys_str_mv AT tisavipatnanthaya authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT anamnartchumpol authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT owattanapanichweerapat authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT apiwattanakulmetha authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT savangnedpakawee authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT prayoonwiwatnaraporn authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT sirithosasitorn authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT rattanathamsakulnatthapon authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports
AT jitprapaikulsanjiraporn authorsresponsetothecommentaryneuromyelitisopticacomplicatingcovidvaccinationsandadditionalcasereports

Ejemplares similares